CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Address
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA 94080
Founded
2021
Number of Employees
9
Website
http://www.cero.bio
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)